Literature DB >> 16177367

Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection.

J F Huntley1, J R Stabel, M L Paustian, T A Reinhardt, J P Bannantine.   

Abstract

Currently, paratuberculosis vaccines are comprised of crude whole-cell preparations of Mycobacterium avium subsp. paratuberculosis. Although effective in reducing clinical disease and fecal shedding, these vaccines have severe disadvantages as well, including seroconversion of vaccinated animals and granulomatous lesions at the site of vaccination. DNA vaccines can offer an alternative approach that may be safer and elicit more protective responses. In an effort to identify protective M. avium subsp. paratuberculosis sequences, a genomic DNA expression library was generated and subdivided into pools of clones (approximately 1,500 clones/pool). The clone pools were evaluated to determine DNA vaccine efficacy by immunizing mice via gene gun delivery and challenging them with live, virulent M. avium subsp. paratuberculosis. Four clone pools resulted in a significant reduction in the amount of M. avium subsp. paratuberculosis recovered from mouse tissues compared to mice immunized with other clone pools and nonvaccinated, infected control mice. One of the protective clone pools was further partitioned into 10 clone arrays of 108 clones each, and four clone arrays provided significant protection from both spleen and mesenteric lymph node colonization by M. avium subsp. paratuberculosis. The nucleotide sequence of each clone present in the protective pools was determined, and coding region functions were predicted by computer analysis. Comparison of the protective clone array sequences implicated 26 antigens that may be responsible for protection in mice. This study is the first study to demonstrate protection against M. avium subsp. paratuberculosis infection with expression library immunization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177367      PMCID: PMC1230947          DOI: 10.1128/IAI.73.10.6877-6884.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

Review 1.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Immunogenicity of a 16.7 kDa Mycobacterium paratuberculosis antigen.

Authors:  Jacob Mullerad; Avi-Hai Hovav; Ronen Nahary; Yolanta Fishman; Herve Bercovier
Journal:  Microb Pathog       Date:  2003-02       Impact factor: 3.738

3.  The immunogenicity of Mycobacterium paratuberculosis 85B antigen.

Authors:  Jacob Mullerad; Israel Michal; Yolanta Fishman; Avi-Hai Hovav; Raúl G Barletta; Herve Bercovier
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

4.  Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing.

Authors:  Tim J Bull; John Hermon-Taylor; Ivo Pavlik; Fouad El-Zaatari; Mark Tizard
Journal:  Microbiology (Reading)       Date:  2000-09       Impact factor: 2.777

5.  A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.

Authors:  M A Skinner; A J Ramsay; G S Buchan; D L Keen; C Ranasinghe; L Slobbe; D M Collins; G W de Lisle; B M Buddle
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

6.  Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice.

Authors:  Jacob Mullerad; Avi-Hai Hovav; Yolanta Fishman; Raúl G Barletta; Herve Bercovier
Journal:  FEMS Immunol Med Microbiol       Date:  2002-09-06

7.  Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis.

Authors:  Cécile Rousseau; Tatiana D Sirakova; Vinod S Dubey; Yann Bordat; Pappachan E Kolattukudy; Brigitte Gicquel; Mary Jackson
Journal:  Microbiology       Date:  2003-07       Impact factor: 2.777

8.  Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.

Authors:  K M Lima; S A Santos; V M F Lima; A A M Coelho-Castelo; J M Rodrigues; C L Silva
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

9.  The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model.

Authors:  Priti Kumar; Rama Rao Amara; Vijay Kumar Challu; Vineet Kumar Chadda; Vijaya Satchidanandam
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model.

Authors:  Jude E Uzonna; Paula Chilton; Robert H Whitlock; Perry L Habecker; Phillip Scott; Raymond W Sweeney
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

View more
  15 in total

1.  Proteome and differential expression analysis of membrane and cytosolic proteins from Mycobacterium avium subsp. paratuberculosis strains K-10 and 187.

Authors:  Thomas J Radosevich; Timothy A Reinhardt; John D Lippolis; John P Bannantine; Judith R Stabel
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

2.  Early immune markers associated with Mycobacterium avium subsp. paratuberculosis infection in a neonatal calf model.

Authors:  J R Stabel; S Robbe-Austerman
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

3.  Coexpression of PPE 34.9 Antigen of Mycobacterium avium subsp. Paratuberculosis with Murine Interferon Gamma in HeLa Cell Line and Study of Their Immunogenicity in Murine Model.

Authors:  Rajib Deb; P P Goswami
Journal:  Biotechnol Res Int       Date:  2011-02-10

4.  Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages.

Authors:  Aneesh Thakur; Claus Aagaard; Anders Stockmarr; Peter Andersen; Gregers Jungersen
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

5.  Host responses to persistent Mycobacterium avium subspecies paratuberculosis infection in surgically isolated bovine ileal segments.

Authors:  Chandrashekhar Charavaryamath; Patricia Gonzalez-Cano; Patrick Fries; Susantha Gomis; Kimberley Doig; Erin Scruten; Andrew Potter; Scott Napper; Philip J Griebel
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

6.  Antemortem and postmortem examinations of the cattle calf naturally infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  Gangadhararao Appana; Dipankar Das; Maroudam Veerasami; Ramachandran Lakshmikanthan Senthilkumar; Munishkumar Durishetty; B Ramalakshmi; Vijay Bahekar; Falguni Mukherjee; Dev Chandran; P Uday Kumar; B Sesikeran; Villuppanoor Alwar Srinivasan
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

Review 7.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

8.  Expression of a Gene Encoding 34.9 kDa PPE Antigen of Mycobacterium avium subsp. paratuberculosis in E. coli.

Authors:  Rajib Deb; P P Goswami
Journal:  Mol Biol Int       Date:  2010-05-18

9.  Paratuberculosis control: a review with a focus on vaccination.

Authors:  Felix Bastida; Ramon A Juste
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-31

10.  A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis.

Authors:  Tim J Bull; Sarah C Gilbert; Saranya Sridhar; Richard Linedale; Nicola Dierkes; Karim Sidi-Boumedine; John Hermon-Taylor
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.